MAP 2015 - Molecular Analysis for Personalised Therapy

We are pleased to announce the first Molecular Analysis for Personalised therapy (MAP) meeting ? a joint initiative from UNICANCER, ESMO and Cancer Research UK.
This new conference will explore the clinical interpretation of molecular tests for metastatic cancers, where the development of new biotechnologies has revolutionised the applications of personalised therapy. We hope to see you at this exciting conference, where we will discuss this emerging topic in detail and offer oncologists practical solutions for clinical treatment.